Top compounds associated with response to E2F5


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K03536150 CTRPv2 pan-cancer AAC 0.24 2e-10
mRNA YM-155 CTRPv2 pan-cancer AAC 0.22 7e-09
mRNA NVP-BEZ235 CTRPv2 pan-cancer AAC 0.25 7e-09
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 1e-08
mRNA decitabine CTRPv2 pan-cancer AAC 0.14 2e-07
mRNA CAL-101 CTRPv2 pan-cancer AAC 0.19 4e-07
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 7e-07
mRNA PI-103 CTRPv2 pan-cancer AAC 0.17 8e-07
mRNA Rapamycin CTRPv2 pan-cancer AAC 0.17 8e-07
mRNA CIL41 CTRPv2 pan-cancer AAC 0.24 1e-06
Download CSV